Criteria for access to deferasirox or deferoxamine for National Defense, Veterans, and First Nations
| Province/group | Deferasirox Access Criteria1 | Deferoxamine Access Criteria2 |
|---|---|---|
| National Defense |
Require iron chelation Deferoxamine is contraindicated |
May be covered3 |
| Veterans | Not covered | May be covered depending on the individual’s (assigned) class of coverage |
|
First Nations NIHB Program |
Not covered | Considered on a case by case basis |
| 1information supplied by Novartis Corporation. 2information supplied by colleagues from across Canada. From: Leitch HA. Canadian Perspectives in Clinical Hematology 2014;2:4-10. 3listed medication. May be on a case by case basis. From: Leitch HA. Canadian Perspectives in Clinical Hematology 2014;2:4-10. | ||